Skip to main content
PMC home page
Annals of Surgery logoLink to Annals of Surgery
. 1999 Mar;229(3):309–312. doi: 10.1097/00000658-199903000-00002

Neoadjuvant therapy.

J E Niederhuber
PMCID: PMC1191694  PMID: 10077041

Full text

PDF
311

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alexander H. R., Grem J. L., Pass H. I., Hamilton M., McAtee N., Fraker D. L., Allegra C. J. Neoadjuvant chemotherapy for locally advanced gastric adenocarcinoma. Oncology (Williston Park) 1993 May;7(5):37-42; discussion 42-4, 49-50, 53. [PubMed] [Google Scholar]
  2. Botet J. F., Lightdale C. J., Zauber A. G., Gerdes H., Winawer S. J., Urmacher C., Brennan M. F. Preoperative staging of gastric cancer: comparison of endoscopic US and dynamic CT. Radiology. 1991 Nov;181(2):426–432. doi: 10.1148/radiology.181.2.1924784. [DOI] [PubMed] [Google Scholar]
  3. Burke E. C., Karpeh M. S., Conlon K. C., Brennan M. F. Laparoscopy in the management of gastric adenocarcinoma. Ann Surg. 1997 Mar;225(3):262–267. doi: 10.1097/00000658-199703000-00004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Chung H. C., Gong S. J., Yoo N. C., Noh S. H., Kim J. H., Roh J. K., Min J. S., Kim B. S., Lee K. B. P-glycoprotein as an intermediate end point of drug resistance to neoadjuvant chemotherapy in locally advanced gastric cancer. Yonsei Med J. 1996 Dec;37(6):397–404. doi: 10.3349/ymj.1996.37.6.397. [DOI] [PubMed] [Google Scholar]
  5. Couper G. W., McAteer D., Wallis F., Norton M., Welch A., Nicolson M., Park K. G. Detection of response to chemotherapy using positron emission tomography in patients with oesophageal and gastric cancer. Br J Surg. 1998 Oct;85(10):1403–1406. doi: 10.1046/j.1365-2168.1998.00963.x. [DOI] [PubMed] [Google Scholar]
  6. Crookes P., Leichman C. G., Leichman L., Tan M., Laine L., Stain S., Baranda J., Casagrande Y., Groshen S., Silberman H. Systemic chemotherapy for gastric carcinoma followed by postoperative intraperitoneal therapy: a final report. Cancer. 1997 May 1;79(9):1767–1775. doi: 10.1002/(sici)1097-0142(19970501)79:9<1767::aid-cncr19>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]
  7. D'Ugo D. M., Persiani R., Caracciolo F., Ronconi P., Coco C., Picciocchi A. Selection of locally advanced gastric carcinoma by preoperative staging laparoscopy. Surg Endosc. 1997 Dec;11(12):1159–1162. doi: 10.1007/s004649900560. [DOI] [PubMed] [Google Scholar]
  8. Estape J., Grau J. J., Lcobendas F., Curto J., Daniels M., Viñolas N., Pera C. Mitomycin C as an adjuvant treatment to resected gastric cancer. A 10-year follow-up. Ann Surg. 1991 Mar;213(3):219–221. doi: 10.1097/00000658-199103000-00006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Fink U., Schuhmacher C., Stein H. J., Busch R., Feussner H., Dittler H. J., Helmberger A., Böttcher K., Siewert J. R. Preoperative chemotherapy for stage III-IV gastric carcinoma: feasibility, response and outcome after complete resection. Br J Surg. 1995 Sep;82(9):1248–1252. doi: 10.1002/bjs.1800820930. [DOI] [PubMed] [Google Scholar]
  10. Gunderson L. L., Burch P. A., Donohue J. H. The role of irradiation as a component of combined modality treatment for gastric cancer. J Infus Chemother. 1995 Summer;5(3):117–124. [PubMed] [Google Scholar]
  11. Gunderson L. L., Sosin H. Adenocarcinoma of the stomach: areas of failure in a re-operation series (second or symptomatic look) clinicopathologic correlation and implications for adjuvant therapy. Int J Radiat Oncol Biol Phys. 1982 Jan;8(1):1–11. doi: 10.1016/0360-3016(82)90377-7. [DOI] [PubMed] [Google Scholar]
  12. Hermans J., Bonenkamp J. J., Boon M. C., Bunt A. M., Ohyama S., Sasako M., Van de Velde C. J. Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomized trials. J Clin Oncol. 1993 Aug;11(8):1441–1447. doi: 10.1200/JCO.1993.11.8.1441. [DOI] [PubMed] [Google Scholar]
  13. Kelsen D., Karpeh M., Schwartz G., Gerdes H., Lightdale C., Botet J., Lauers G., Klimstra D., Huang Y., Saltz L. Neoadjuvant therapy of high-risk gastric cancer: a phase II trial of preoperative FAMTX and postoperative intraperitoneal fluorouracil-cisplatin plus intravenous fluorouracil. J Clin Oncol. 1996 Jun;14(6):1818–1828. doi: 10.1200/JCO.1996.14.6.1818. [DOI] [PubMed] [Google Scholar]
  14. Lowy A. M., Mansfield P. F., Leach S. D., Pazdur R., Dumas P., Ajani J. A. Response to neoadjuvant chemotherapy best predicts survival after curative resection of gastric cancer. Ann Surg. 1999 Mar;229(3):303–308. doi: 10.1097/00000658-199903000-00001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Merajver S. D., Weber B. L., Cody R., Zhang D., Strawderman M., Calzone K. A., LeClaire V., Levin A., Irani J., Halvie M. Breast conservation and prolonged chemotherapy for locally advanced breast cancer: the University of Michigan experience. J Clin Oncol. 1997 Aug;15(8):2873–2881. doi: 10.1200/JCO.1997.15.8.2873. [DOI] [PubMed] [Google Scholar]
  16. Nakata B., Chung K. H., Muguruma K., Yamashita Y., Inoue T., Matsuoka T., Onoda N., Kato Y., Sakurai M., Sowa M. Changes in tumor marker levels as a predictor of chemotherapeutic effect in patients with gastric carcinoma. Cancer. 1998 Jul 1;83(1):19–24. [PubMed] [Google Scholar]
  17. Ng C. S., Husband J. E., MacVicar A. D., Ross P., Cunningham D. C. Correlation of CT with histopathological findings in patients with gastric and gastro-oesophageal carcinomas following neoadjuvant chemotherapy. Clin Radiol. 1998 Jun;53(6):422–427. doi: 10.1016/s0009-9260(98)80270-5. [DOI] [PubMed] [Google Scholar]
  18. Nigro N. D., Vaitkevicius V. K., Considine B., Jr Combined therapy for cancer of the anal canal: a preliminary report. Dis Colon Rectum. 1974 May-Jun;17(3):354–356. doi: 10.1007/BF02586980. [DOI] [PubMed] [Google Scholar]
  19. Plukker J. T., Mulder N. H., Sleijfer D. T., Grond J., Verschueren R. C. Chemotherapy and surgery for locally advanced cancer of the cardia and fundus: phase II study with methotrexate and 5-fluorouracil. Br J Surg. 1991 Aug;78(8):955–958. doi: 10.1002/bjs.1800780820. [DOI] [PubMed] [Google Scholar]
  20. Rosen G., Marcove R. C., Caparros B., Nirenberg A., Kosloff C., Huvos A. G. Primary osteogenic sarcoma: the rationale for preoperative chemotherapy and delayed surgery. Cancer. 1979 Jun;43(6):2163–2177. doi: 10.1002/1097-0142(197906)43:6<2163::aid-cncr2820430602>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]
  21. Suga S., Iwase H., Shimada M., Nishio Y., Ichihara T., Ichihara S., Kusugami K., Saito H. Neoadjuvant chemotherapy in scirrhous cancer of the stomach using uracil and tegafur and cisplatin. Intern Med. 1996 Dec;35(12):930–936. doi: 10.2169/internalmedicine.35.930. [DOI] [PubMed] [Google Scholar]
  22. Swisher S. G., Holmes E. C., Hunt K. K., Doty J. E., Zinner M. J., McFadden D. W. The role of neoadjuvant therapy in surgically resectable esophageal cancer. Arch Surg. 1996 Aug;131(8):819–825. doi: 10.1001/archsurg.1996.01430200029005. [DOI] [PubMed] [Google Scholar]
  23. Tester W., Caplan R., Heaney J., Venner P., Whittington R., Byhardt R., True L., Shipley W. Neoadjuvant combined modality program with selective organ preservation for invasive bladder cancer: results of Radiation Therapy Oncology Group phase II trial 8802. J Clin Oncol. 1996 Jan;14(1):119–126. doi: 10.1200/JCO.1996.14.1.119. [DOI] [PubMed] [Google Scholar]
  24. Yonemura Y., Kinoshita K., Fujimura T., Fushida S., Sawa T., Matsuki N., Tanaka S., Kamata T., Takashima T., Miyazaki I. Correlation of the histological effects and survival after neoadjuvant chemotherapy on gastric cancer patients. Hepatogastroenterology. 1996 Sep-Oct;43(11):1260–1272. [PubMed] [Google Scholar]
  25. Yu W., Whang I., Suh I., Averbach A., Chang D., Sugarbaker P. H. Prospective randomized trial of early postoperative intraperitoneal chemotherapy as an adjuvant to resectable gastric cancer. Ann Surg. 1998 Sep;228(3):347–354. doi: 10.1097/00000658-199809000-00007. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES